- Home
- CSBR vs XTNT Comparison
CSBR vs XTNT Comparison
Compare CSBR & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- XTNT
- Stock Information
- Founded
- CSBR 1985
- XTNT N/A
- Country
- CSBR United States
- XTNT United States
- Employees
- CSBR N/A
- XTNT N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CSBR Health Care
- XTNT Health Care
- Exchange
- CSBR Nasdaq
- XTNT Nasdaq
- Market Cap
- CSBR 65.9M
- XTNT 74.1M
- IPO Year
- CSBR 1986
- XTNT N/A
- Fundamental
- Price
- CSBR $4.44
- XTNT $0.41
- Analyst Decision
- CSBR Strong Buy
- XTNT Strong Buy
- Analyst Count
- CSBR 1
- XTNT 1
- Target Price
- CSBR $6.00
- XTNT $3.00
- AVG Volume (30 Days)
- CSBR 11.4K
- XTNT 105.5K
- Earning Date
- CSBR 12-10-2024
- XTNT 11-12-2024
- Dividend Yield
- CSBR N/A
- XTNT N/A
- EPS Growth
- CSBR N/A
- XTNT N/A
- EPS
- CSBR N/A
- XTNT N/A
- Revenue
- CSBR $51,655,000.00
- XTNT $113,862,000.00
- Revenue This Year
- CSBR $9.27
- XTNT $31.82
- Revenue Next Year
- CSBR $9.76
- XTNT $13.64
- P/E Ratio
- CSBR N/A
- XTNT N/A
- Revenue Growth
- CSBR N/A
- XTNT 45.11
- 52 Week Low
- CSBR $3.60
- XTNT $0.39
- 52 Week High
- CSBR $7.13
- XTNT $1.45
- Technical
- Relative Strength Index (RSI)
- CSBR 51.57
- XTNT 22.17
- Support Level
- CSBR $4.26
- XTNT $0.39
- Resistance Level
- CSBR $4.70
- XTNT $0.54
- Average True Range (ATR)
- CSBR 0.26
- XTNT 0.03
- MACD
- CSBR 0.02
- XTNT -0.01
- Stochastic Oscillator
- CSBR 64.86
- XTNT 12.81
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.